Literature DB >> 8871181

Inward and outward permeability of the blood-retinal barrier in experimental myopia.

A Yoshida1, S Ishiko, M Kojima.   

Abstract

BACKGROUND: To investigate the pathophysiology of the retina in myopia, vitreous fluorophotometry was used to evaluate the permeability of the blood-retinal barrier (BRB) in experimentally induced myopia in cynomolgus monkeys.
METHODS: Five animals underwent unilateral eyelid suturing. The suture was removed temporarily at 3, 10, 16, 28 and 36 months, and the dioptric power and axial length were measured in both eyes. Vitreous fluorophotometry was performed before and 60 min after intravenous injection of fluorescein-Na. BRB inward permeability (P(in)) was determined by a computer simulation method. At 36 months, fluorescein-Na was injected into the vitreous cavity, and the intraocular fluorescence was measured. BRB outward permeability (P(out)) was determined by the computer simulation method.
RESULTS: Significant myopia developed by 10 months after suturing and progressed thereafter. Starting at 10 months, the P(in) of sutured eyes increased significantly compared with control fellow eyes, and the increase continued throughout the observation period. At 36 months, the BRB P(out) was significantly lower (P < 0.05) in the myopic than in the emmetropic fellow eyes, suggesting decreased active transport mechanisms at the BRB in myopia.
CONCLUSION: Our study demonstrated, for the first time, abnormal permeability of the BRB in myopic monkey eyes. Such abnormal permeability may play an important role in the development in human myopes of retinal and vitreous changes such as retinal detachment. Thus, simply correcting refractive errors surgically may not represent a cure for myopia. Patients who have had refractive surgery to correct myopia should also be closely followed up by vitreo-retinal specialists to manage vitreo-retinal disorders in originally myopic eyes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871181     DOI: 10.1007/bf02343079

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  Outward permeability of the blood-retinal barrier.

Authors:  A Yoshida; S Ishiko; M Kojima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Gel injection adjustable keratoplasty.

Authors:  G Simon; J M Parel; W Lee; G N Kervick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

3.  Dopamine synthesis and metabolism in rhesus monkey retina: development, aging, and the effects of monocular visual deprivation.

Authors:  P M Iuvone; M Tigges; A Fernandes; J Tigges
Journal:  Vis Neurosci       Date:  1989       Impact factor: 3.241

4.  [Investigation of the vitreo-retino-ciliary barrier by vitreous fluorophotometry. 5. Alteration of the inward permeability of the blood-retinal barrier and the diffusion coefficient of fluorescein in the vitreous with aging in normal subjects].

Authors:  A Yoshida; K Murakami; M Kojima
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1986-04

5.  Transport of fluorescein monoglucuronide out of the vitreous.

Authors:  S Kitano; S Nagataki
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-06       Impact factor: 4.799

6.  Study of fluorescein glucuronide. II. A comparative ocular kinetic study of fluorescein and fluorescein glucuronide.

Authors:  C Seto; M Araie; M Takase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

7.  Myopia and eye enlargement after neonatal lid fusion in monkeys.

Authors:  T N Wiesel; E Raviola
Journal:  Nature       Date:  1977-03-03       Impact factor: 49.962

8.  Effects of apomorphine, a dopamine receptor agonist, on ocular refraction and axial elongation in a primate model of myopia.

Authors:  P M Iuvone; M Tigges; R A Stone; S Lambert; A M Laties
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-04       Impact factor: 4.799

9.  Results one year after using the 193-nm excimer laser for photorefractive keratectomy in mild to moderate myopia.

Authors:  A R Talley; D R Hardten; N A Sher; M S Kim; D J Doughman; E Carpel; C S Ostrov; S S Lane; P Parker; R L Lindstrom
Journal:  Am J Ophthalmol       Date:  1994-09-15       Impact factor: 5.258

10.  Retinal detachment after refractive surgery for myopia.

Authors:  A Rodriguez; H Camacho
Journal:  Retina       Date:  1992       Impact factor: 4.256

View more
  5 in total

1.  Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study.

Authors:  Y-F Shih; T-C Ho; C K Hsiao; L L-K Lin
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  New loci for refractive errors and ocular biometric parameters in young Chinese Han adults.

Authors:  Yunyun Sun; Zi-Bing Jin; Shifei Wei; Hongyan Jia; Kai Cao; Jianping Hu; Caixia Lin; Wenzai An; Jiyuan Guo; He Li; Jing Fu; Shi-Ming Li; Ningli Wang
Journal:  Sci China Life Sci       Date:  2022-03-14       Impact factor: 10.372

3.  Characteristics of patients with a favorable natural course of myopic choroidal neovascularization.

Authors:  Kengo Hayashi; Kyoko Ohno-Matsui; Takeshi Yoshida; Kanako Kobayashi; Ariko Kojima; Noriaki Shimada; Kenjiro Yasuzumi; Soh Futagami; Takashi Tokoro; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-28       Impact factor: 3.117

4.  Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia.

Authors:  Ariko Kojima; Kyoko Ohno-Matsui; Satoshi Teramukai; Takeshi Yoshida; Yoko Ishihara; Kanako Kobayashi; Noriaki Shimada; Kenjiro Yasuzumi; Soh Futagami; Takashi Tokoro; Manabu Mochizuki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-28       Impact factor: 3.117

5.  Assessment for Macular Thickness after Uncomplicated Phacoemulsification Using Optical Coherence Tomography.

Authors:  Byung-Jin Kim; Ye Jin Ahn; Hye-Young Oh; Soon Il Choi; Young-Sik Yoo; Woong-Joo Whang; Yong-Soo Byun; Mee-Yon Lee; Choun-Ki Joo
Journal:  Korean J Ophthalmol       Date:  2022-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.